Subclinical inflammation, C-reactive protein and cardiovascular risk
Heald, A.H.
Indian Journal of Medical Research 125(4): 502-504
2007
ISSN/ISBN: 0019-5340 PMID: 17598934 Document Number: 612669
Document emailed within 1 workday
Related Documents
Koenig, W. 2001: C-Reactive protein and cardiovascular risk: has the time come for screening the general population? Clinical Chemistry 47(1): 9-10Snežana Jovičić; Ignjatovi, S.ć; Dajak, M.; Kangrga, R.; Majki, N.ć-Singh 2009: Association of Lipid and Inflammatory Markers with C-Reactive Protein in Cardiovascular Risk Assessment for Primary Prevention Clinical Laboratory 55(11-12): 411-419
Cohen-Aubart, F.; Jublanc, C.; Chiche, F.; Bruckert, E. 2007: Subclinical hypothyroidism: a cardiovascular risk factor? Archives des Maladies du Coeur et des Vaisseaux 100(3): 213-216
Sharma, R.; Sharma, T.K.; G.Kaushik, G.; Sharma, S.; Vardey, S.K.; Sinha, M. 2011: Subclinical Hypothyroidism and its Association with Cardiovascular Risk Factors Clinical Laboratory 57(9-10): 719-724
Luboshitzky, R.; Herer, P. 2004: Cardiovascular risk factors in middle-aged women with subclinical hypothyroidism Neuro Endocrinology Letters 25(4): 262-266
Tauchmanovà, L.; Rossi, R.; Biondi, B.; Pulcrano, M.; Nuzzo, V.; Palmieri, E.-A.; Fazio, S.; Lombardi, G. 2002: Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk Journal of Clinical Endocrinology and Metabolism 87(11): 4872-4878
Titov, V.N. 2003: C-Reactive protein. Activation of inflammation by intensifying absorption of fatty acids by cells of the friable connective tissue Klinicheskaia Laboratornaia Diagnostika 20(7): 3-9
Martínez-Alvarado, Mía.Del.Rocío.; Juárez-Rojas, J.Gabriel.; Medina-Urrutia, Aída.Xóchitl.; Cardoso-Saldaña, G.Celestino.; González-Salazar, Mía.Del.Carmen.; Posadas-Sánchez, R.; Jorge-Galarza, E.; Mendoza-Pérez, E.; Vargas-Alarcón, G.; Posadas-Romero, C. 2014: Association of fatty liver with cardiovascular risk factors and subclinical atherosclerosis in a Mexican population Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 66(5): 407-414
Stevermer, J.J. 2003: Does C-reactive protein predict cardiovascular events in women better than LDL? Journal of Family Practice 52(3): 185-186
Rus, H.; Niculescu, F.I. 1997: Inflammation, aspirin, and the risk of cardiovascular disease New England Journal of Medicine 337(6): 423; Author Reply 423-424
De Maat, M.P.M.; Madsen, J.S.; Langdahl, B.; Bladbjerg, E.M.; Tofteng, C.L.; Abrahamsen, B.; Rejnmark, L.; Brixen, K.; Christensen, K.; Jespersen, J.ør.; Kristensen, S.ør.R. 2007: Genetic variation in estrogen receptor, C-reactive protein and fibrinogen does not predict the plasma levels of inflammation markers after longterm hormone replacement therapy Thrombosis and Haemostasis 97(2): 234-239
Nomoto, K.; Oguchi, S.; Watanabe, I.; Kushiro, T.; Kanmatsuse, K. 2003: Involvement of inflammation in acute coronary syndromes assessed by levels of high-sensitivity C-reactive protein, matrix metalloproteinase-9 and soluble vascular-cell adhesion molecule-1 Journal of Cardiology 42(5): 201-206
Nanda, N.; Bobby, Z.; Hamide, A. 2011: Inflammation and oxidative stress in hypothyroids: additive effects on cardiovascular risk Indian Journal of Physiology and Pharmacology 55(4): 351-356
T, D.; Mv, K. 2020: Assessment of Cardiovascular Risk with Atherogenic Markers in Subclinical Hypothyroidism: with Special Reference to Carotid Intima Media Thickness (CIMT) and High Sensitive CRP (hsCRP) Journal of the Association of Physicians of India 68(1): 45
Baptista-González, H.A.; Maciel-Corrales, A.L.; Ibarra-Camacho, A.; Lozano-González, C. 1989: Determination of C-reactive protein in low-risk newborn infants Boletin Medico del Hospital Infantil de Mexico 46(7): 482-484
Gonzalez-Gay, M.A.; Llorca, J.; Garcia-Unzueta, M.T.; Gonzalez-Juanatey, C.; De Matias, J.M.; Martin, J.; Redelinghuys, M.; Woodiwiss, A.J.; Norton, G.R.; Dessein, P.H. 2008: High-grade inflammation, circulating adiponectin concentrations and cardiovascular risk factors in severe rheumatoid arthritis Clinical and Experimental Rheumatology 26(4): 596-603
Cheng, J.; Zhao, D.; Wang, W.; Sun, J.-Y.; Wu, Z.-S. 2007: Study on the interaction between C-reactive protein and hypertension on the risk of carotid plaque Zhonghua Liu Xing Bing Xue Za Zhi 28(12): 1211-1214
Racek, J.; Racková, M. 2002: Less common risk factors for atherogenesis--homocysteine, lipoprotein (a) and C-reactive protein Casopis Lekaru Ceskych 141(19): 605-609
Mathai, E.; Christopher, U.; Mathai, M.; Jana, A.K.; Rose, D.; Bergstrom, S. 2004: Is C-reactive protein level useful in differentiating infected from uninfected neonates among those at risk of infection? Indian Pediatrics 41(9): 895-900
Mathai, E.; Christopher, U.; Mathai, M.; Jana, A.K.; Rose, D.; Bergstrom, S. 2004: Is C-reactive protein level useful in differentiating infected from uninfected neonates among those at risk of infection? Indian Pediatrics 41(9): 895-900